A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
BIO-PATH HOLDINGS, INC.
BPTH
$2K
Mkt Cap
$0.03
+0.00%
BIO-PATH HOLDINGS, INC. operates in the Pharmaceutical Preparations industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 37K | - | 0 | 0 |
| Net Income | -8.7M | - | - | -6.8M | -5.5M | -4.5M |
| EPS | $-1.03 | $-129.42 | $-1,439.10 | $-63,519.45 | $-5.40 | $-4.50 |
| Free Cash Flow | 0 | -6.1M | -8.5M | -8.5M |
| Metric | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | N/A | 37K | 0 | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | 1.1M | 5.8M | 1.6M | 3.0M | 5.5M | 5.5M | 4.6M | 6.3M |
| SG&A | 6.1M | 986K | 8.7M | 2.7M | 2.5M | 3.0M | 3.5M | 3.4M | 2.3M |
| EBIT | -9.9M | -2.6M | -16M | -4.5M | -5.5M | -8.5M | -9.0M | -8.6M | -8.6M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | -24232.4% | N/A | 0.0% |
| Net Income | -9.5M | -2.6M | -15M | -4.5M | -5.5M | -6.8M | N/A | N/A | -8.7M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 345K | 345K | 690K | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||
| ROIC | N/M | -137.8% | N/M | -29.3% | -44.2% | -81.3% | N/A | N/A | N/M |
| ROE | -330.6% | -104.8% | -321.9% | N/A | -44.2% | -74.8% | N/A | N/A | 0.0% |
| ROA | -301.2% | -92.6% | -303.2% | -44.0% | -41.7% | -58.8% | N/A | N/A | -1284.3% |
| Cash Flow | |||||||||
| Op. Cash Flow | -5.0M | -2.0M | -9.4M | -3.8M | -5.0M | -8.1M | -8.0M | -6.1M | -1.6M |
| Free Cash Flow | -5.9M | -2.0M | -10M | -3.9M | -5.0M | -8.5M | -8.5M | -6.1M | 0 |
| Owner Earnings | -8.8M | -3.0M | -14M | -4.2M | -5.4M | -9.0M | -9.1M | -7.3M | -2.4M |
| CapEx | 860K | 0 | 885K | 123K | 0 | 338K | 538K | 17K | 0 |
| Maint. CapEx | 791K | 928K | 1.1M | 10K | 51K | 94K | 330K | 592K | 592K |
| Growth CapEx | 68K | N/A | 0 | 113K | N/A | 244K | 208K | 0 | 0 |
| D&A | 791K | 928K | 1.1M | 10K | 51K | 94K | 330K | 592K | 592K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 3.0M | 63K | 3.7M | 404K | 369K | 784K | 793K | 554K | 168K |
| Debt Repayment | 15K | 0 | 15K | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||
| Net Debt | -952K | -534K | -7.1M | -14M | -8.9M | N/A | N/A | N/A | 549K |
| Cash & Equiv. | 952K | 534K | 3.6M | 14M | 8.9M | 9.4M | 6.0M | 1.0M | 12K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | N/A | N/A | N/A | 50K |
| Debt/Equity | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.48 | 0.10 | 1.09 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 2.9M | 2.0M | 4.8M | N/A | 9.8M | 8.2M | 8.1M | 1.2M | -8.5M |
| Total Assets | 3.2M | 2.3M | 5.1M | 15M | 11M | 12M | 8.9M | 2.5M | 677K |
| Total Liabilities | 316K | 329K | 295K | N/A | 937K | 4.0M | 791K | 1.3M | 9.2M |
| Intangibles | 2.1M | 1.6M | 1.4M | 1.3M | 1.1M | 929K | 769K | 0 | 0 |
| Retained Earnings | N/A | N/A | N/A | -20M | -25M | -32M | -39M | -48M | -126M |
| Working Capital | 838K | 442K | 3.4M | 14M | 8.7M | 9.6M | 6.6M | 812K | -8.5M |
| Current Assets | 1.2M | 772K | 3.7M | 14M | 9.6M | 11M | 7.4M | 2.1M | 677K |
| Current Liabilities | 316K | 329K | 295K | 562K | 937K | 1.1M | 791K | 1.3M | 9.2M |
| Per Share Data | |||||||||
| EPS | -880.00 | -3.60 | -1,240.00 | -4.50 | -5.40 | -63,519.45 | -1,439.10 | -129.42 | -1.03 |
| Owner EPS | -809.99 | -4.16 | -1,140.43 | -4.21 | -5.36 | -84,937.26 | -1,441,269.84 | -96.22 | -0.26 |
| Book Value | 268.64 | 2.81 | 385.27 | N/A | 9.70 | 77,540.78 | 1,280,476.19 | 16.12 | -0.91 |
| Cash Flow/Share | -465.15 | -2.78 | -753.29 | -3.80 | -4.94 | -76,675.03 | -1,263,015.87 | -81.05 | -0.87 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 0.0M | 0.7M | 0.0M | 1.0M | 1.0M | 0.0M | 0.0M | 0.1M | 9.3M |
| Valuation | |||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.0 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 11.2 | 43.4 | N/A | 13.7 | 14.7 | 13.1 | 7.4 | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | -8.8% | -4.9% | -1.6% | -3.7% | -7.0% | -8.1% | -68.0% | N/A |
| Market Cap | 0 | 23M | 208M | 253M | 135M | 121M | 105M | 9.0M | 280K |
| Avg. Price | 0.00 | 1,345.18 | 3,904.29 | 11,699.44 | 6,138.57 | 6,973.44 | 2,134.70 | 550.00 | 0.03 |
| Year-End Price | 0.00 | 1,400.00 | 12,720.00 | 11,200.00 | 5,920.00 | 5,240.00 | 840.00 | 72.00 | 0.03 |
BIO-PATH HOLDINGS, INC. passes 0 of 9 quality checks, indicating weak fundamentals.
BIO-PATH HOLDINGS, INC. (BPTH) has a 5-year average return on invested capital (ROIC) of -51.6%. This is below average and may indicate limited pricing power.
BIO-PATH HOLDINGS, INC. (BPTH) has a market capitalization of $280K. It is classified as a small-cap stock.
BIO-PATH HOLDINGS, INC. (BPTH) does not currently pay a regular dividend.
BIO-PATH HOLDINGS, INC. (BPTH) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
BIO-PATH HOLDINGS, INC. (BPTH) generated $-6 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
BIO-PATH HOLDINGS, INC. (BPTH) has a debt-to-equity ratio of 1.09. This indicates moderate leverage.
BIO-PATH HOLDINGS, INC. (BPTH) reported earnings per share (EPS) of $-129.42 in its most recent fiscal year.
| -5.0M |
| -3.9M |
| ROIC | -1002.1% | - | - | -81.3% | -44.2% | -29.3% |
|---|
| Gross Margin | - | - | - | - | - | - |
|---|
| Debt/Equity | 0.00 | 1.09 | 0.10 | 0.48 | 0.00 | - |
|---|
| Dividends/Share | $0.00 | - | - | - | - | - |
|---|
| Operating Income | -8.6M | -8.6M | -9.0M | -8.5M | -5.5M | -4.5M |
|---|
| Operating Margin | 0.0% | - | -24232.4% | - | - | - |
|---|
| ROE | 0.0% | - | - | -74.8% | -44.2% | - |
|---|
| Shares Outstanding | 9M | 0M | 0M | 0M | 1M | 1M |
|---|
The Ledger Terminal provides 8 years of financial data for BIO-PATH HOLDINGS, INC. (BPTH), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
BIO-PATH HOLDINGS, INC. (BPTH) has a book value per share of $16.12, based on its most recent annual SEC filing.
No recent press releases.